chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity
Clinical narrative: swollen lymph node in neck area; arm sensitivity; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sensitivity) and LYMPHADENOPATHY (swollen lymph node in neck area) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm sensitivity). On 19-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node in neck area). At the time of the report, PAIN IN EXTREMITY (arm sensitivity) and LYMPHADENOPATHY (swollen lymph node in neck area) outcome was unknown. Not Provided          No concomitant and treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Swelling
Clinical narrative: Swollen under her armpit, near breast; lymph nodes are swollen; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swollen under her armpit, near breast) and LYMPHADENOPATHY (lymph nodes are swollen) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 031M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included CALCIUM, VITAMIN C [ASCORBIC ACID] and VITAMIN D NOS for an unknown indication.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced SWELLING (Swollen under her armpit, near breast) and LYMPHADENOPATHY (lymph nodes are swollen). At the time of the report, SWELLING (Swollen under her armpit, near breast) and LYMPHADENOPATHY (lymph nodes are swollen) outcome was unknown.            Other relevant concomitant medicines included multi vitamin.  The action taken with mRNA-1273 in response to the event was not applicable.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: "hurt to raise the arm"; "soreish arm"; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA ("soreish arm") and PAIN IN EXTREMITY ("hurt to raise the arm") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced MYALGIA ("soreish arm") and PAIN IN EXTREMITY ("hurt to raise the arm"). At the time of the report, MYALGIA ("soreish arm") and PAIN IN EXTREMITY ("hurt to raise the arm") outcome was unknown. Not Provided          No concomitant and treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Tenderness
Clinical narrative: Sore arm; Tenderness; Circular rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), TENDERNESS (Tenderness) and RASH (Circular rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), TENDERNESS (Tenderness) and RASH (Circular rash). At the time of the report, PAIN IN EXTREMITY (Sore arm), TENDERNESS (Tenderness) and RASH (Circular rash) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.   This case was linked to MOD21-058317 (Linked Report).; Sender's Comments:  MOD21-058317:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder and neck pain pretty bad) and NECK PAIN (shoulder and neck pain pretty bad, sometimes the pain is as severe as an electric shock) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced ARTHRALGIA (shoulder and neck pain pretty bad) and NECK PAIN (shoulder and neck pain pretty bad, sometimes the pain is as severe as an electric shock). At the time of the report, ARTHRALGIA (shoulder and neck pain pretty bad) and NECK PAIN (shoulder and neck pain pretty bad, sometimes the pain is as severe as an electric shock) outcome was unknown.            No concomitant and treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable. It was reporter she did not experience any side effects at all after the second shot. She went on to state she could tell if the shoulder and neck pain she experienced with the first shot was from the vaccine.    Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Followup information was received on 08 May 2021, dosage related information was updated.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No medical history information is reported.  Concomitant products included LEVOTHYROXINE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 30-Sep-2020 and the estimated date of delivery was 05-Jul-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fourth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Oct-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications included prenatal vitamins No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Constipation, Decreased appetite, Diarrhoea, Headache
Clinical narrative: supper achy, like getting the flu; Diarrhea; constipation; lost his appetite; bad headache across the back of his head; chills  he was hot and cold all day; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DIARRHOEA (Diarrhea), CONSTIPATION (constipation), DECREASED APPETITE (lost his appetite) and HEADACHE (bad headache across the back of his head) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001421A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DIARRHOEA (Diarrhea), CONSTIPATION (constipation), DECREASED APPETITE (lost his appetite), HEADACHE (bad headache across the back of his head) and CHILLS (chills  he was hot and cold all day). At the time of the report, INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DIARRHOEA (Diarrhea), CONSTIPATION (constipation), DECREASED APPETITE (lost his appetite), HEADACHE (bad headache across the back of his head) and CHILLS (chills  he was hot and cold all day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.  One week after vaccination, the patient had bad headache across the back of head, super achy like getting the flu and lost appetite. Next day morning, the patient also had chills- hot and cold all day. On day 3 headache continued and by day 4 patient was better. On an unknown date, the patient experienced constipation and diarrhea.   This case was linked to MOD-2021-115907 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up received on 08-05-2021:Significant information received, Added constipation and diarrhea as events.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: supper achy, like getting the flu; Diarrhea; constipation; lost his appetite; bad headache across the back of his head; chills  he was hot and cold all day; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DIARRHOEA (Diarrhea), CONSTIPATION (constipation), DECREASED APPETITE (lost his appetite) and HEADACHE (bad headache across the back of his head) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001421A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DIARRHOEA (Diarrhea), CONSTIPATION (constipation), DECREASED APPETITE (lost his appetite), HEADACHE (bad headache across the back of his head) and CHILLS (chills  he was hot and cold all day). At the time of the report, INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DIARRHOEA (Diarrhea), CONSTIPATION (constipation), DECREASED APPETITE (lost his appetite), HEADACHE (bad headache across the back of his head) and CHILLS (chills  he was hot and cold all day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.  One week after vaccination, the patient had bad headache across the back of head, super achy like getting the flu and lost appetite. Next day morning, the patient also had chills- hot and cold all day. On day 3 headache continued and by day 4 patient was better. On an unknown date, the patient experienced constipation and diarrhea.   This case was linked to MOD-2021-115907 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up received on 08-05-2021:Significant information received, Added constipation and diarrhea as events.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (For next 2 days, patient's arm was red and sore around injection site after receiving 1st dose), VACCINATION SITE PAIN (For next 2 days, patient's arm was red and sore around injection site after receiving 1st dose), VACCINATION SITE PRURITUS (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm), VACCINATION SITE WARMTH (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm) and VACCINATION SITE SWELLING (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 10-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (For next 2 days, patient's arm was red and sore around injection site after receiving 1st dose) and VACCINATION SITE PAIN (For next 2 days, patient's arm was red and sore around injection site after receiving 1st dose). On 18-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm), VACCINATION SITE WARMTH (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm) and VACCINATION SITE SWELLING (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm). On 13-Mar-2021, VACCINATION SITE ERYTHEMA (For next 2 days, patient's arm was red and sore around injection site after receiving 1st dose) and VACCINATION SITE PAIN (For next 2 days, patient's arm was red and sore around injection site after receiving 1st dose) had resolved. At the time of the report, VACCINATION SITE PRURITUS (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm), VACCINATION SITE WARMTH (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm) and VACCINATION SITE SWELLING (8 days later, she noticed that the arm was itching, warm and swollen at injection site on right arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment products reported. Concomitant products included Cholesterol medication, Low dose Aspirin and Multi-vitamin.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Too Much dizzy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Too Much dizzy) and HEADACHE (Headache) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced DIZZINESS (Too Much dizzy) and HEADACHE (Headache). At the time of the report, DIZZINESS (Too Much dizzy) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: TCR Form  received on 09-MAY-2021 and it doesn't have any new information
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Malaise, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Having an UTI), MALAISE (Just did not feel well), HEADACHE (Slight headache), CHILLS (Developed chills so bad she was shivering) and PYREXIA (Developed a fever of 99.0) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A210A and 016M2UA or OA) for COVID-19 vaccination.     Concurrent medical conditions included UTI.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced MALAISE (Just did not feel well), HEADACHE (Slight headache) and CHILLS (Developed chills so bad she was shivering). On 18-Mar-2021, the patient experienced URINARY TRACT INFECTION (Having an UTI) and PYREXIA (Developed a fever of 99.0). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (Having an UTI), MALAISE (Just did not feel well) and HEADACHE (Slight headache) outcome was unknown and CHILLS (Developed chills so bad she was shivering) and PYREXIA (Developed a fever of 99.0) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 99.0 (High) Through out, the day her fever ranges from 102.8-103. On 19-Mar-2021, Body temperature: 102 (High) Around 102.         No concomitant medication details was reported. Treatment medications included acetaminophen, unspecified antibiotics, and AZO. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Having an UTI), MALAISE (Just did not feel well), HEADACHE (Slight headache), CHILLS (Developed chills so bad she was shivering) and PYREXIA (Developed a fever of 99.0) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A210A and 016M2UA or OA) for COVID-19 vaccination.     Concurrent medical conditions included UTI.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced MALAISE (Just did not feel well), HEADACHE (Slight headache) and CHILLS (Developed chills so bad she was shivering). On 18-Mar-2021, the patient experienced URINARY TRACT INFECTION (Having an UTI) and PYREXIA (Developed a fever of 99.0). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (Having an UTI), MALAISE (Just did not feel well) and HEADACHE (Slight headache) outcome was unknown and CHILLS (Developed chills so bad she was shivering) and PYREXIA (Developed a fever of 99.0) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 99.0 (High) Through out, the day her fever ranges from 102.8-103. On 19-Mar-2021, Body temperature: 102 (High) Around 102.         No concomitant medication details was reported. Treatment medications included acetaminophen, unspecified antibiotics, and AZO. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Just had a little fever took Tylenol but was not hospitalized.) in September 2020. Concomitant products included METOPROLOL, RIVAROXABAN (XARELTO), SIMVASTATIN, OMEPRAZOLE, VITAMIN D NOS, ZINC and PARACETAMOL (TYLENOL) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PALPITATIONS (Palpitations). At the time of the report, PALPITATIONS (Palpitations) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported.   This case was linked to MOD-2021-051779 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Stiffness muscle; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness muscle ) and PAIN IN EXTREMITY (Pain in arm ) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (She had surgery in her left arm.).    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness muscle ) and PAIN IN EXTREMITY (Pain in arm ). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness muscle ) and PAIN IN EXTREMITY (Pain in arm ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided. No concomitant medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: TCR on 08-May-2021 included no new information. Consumer doesn't want to provide email ID over phone and She doesn't have access to fax.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder, Visual impairment
Clinical narrative: She lost part of her vision/Her vision is distorted; She is having issues with one of her eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (She is having issues with one of her eyes) and VISUAL IMPAIRMENT (She lost part of her vision/Her vision is distorted) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy, Drug allergy and Allergy (Other products.). Concomitant products included HYOSCYAMINE from 20-Feb-2021 to an unknown date for Ache stomach, AMLODIPINE BESYLATE from 10-Jan-2021 to an unknown date and BISOPROLOL FUMARATE (BISOPROLOL FUMERATE) from 10-Jan-2021 to an unknown date for Blood pressure management, FUROSEMIDE from 25-Mar-2021 to an unknown date for Diuretic effect, DESIPRAMINE from 18-Feb-2021 to an unknown date for Stomach ache.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EYE DISORDER (She is having issues with one of her eyes). On 25-Jun-2021, the patient experienced VISUAL IMPAIRMENT (She lost part of her vision/Her vision is distorted). On 25-Jun-2021, VISUAL IMPAIRMENT (She lost part of her vision/Her vision is distorted) had resolved. At the time of the report, EYE DISORDER (She is having issues with one of her eyes) had resolved. Not Provided          No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Patient demographics, dose one details, concomitant medications were added and dose 2 details and event details and outcome was updated.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm to touch; Itchiness at injection site; Hardness; Red/brown circles; Raised skin/ swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Itchiness at injection site), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE ERYTHEMA (Red/brown circles) and VACCINATION SITE SWELLING (Raised skin/ swelling) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Itchiness at injection site), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE ERYTHEMA (Red/brown circles) and VACCINATION SITE SWELLING (Raised skin/ swelling). At the time of the report, VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Itchiness at injection site), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE ERYTHEMA (Red/brown circles) and VACCINATION SITE SWELLING (Raised skin/ swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details was not reported by the reporter.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Painful arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Body temperature: 101 (High) 101 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was on unspecified blood pressure medication.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash erythematous, Vaccination site bruising, Vaccination site dysaesthesia, Vaccination site movement impairment
Clinical narrative: Arm tight like a sunburn; Arm hot to the touch; Big red circle; Arm pain; Covid arm; Left arm a little splotchy; Left arm felt weird; Arm felt tight; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE DYSAESTHESIA (Left arm felt weird), VACCINATION SITE MOVEMENT IMPAIRMENT (Arm felt tight), RASH ERYTHEMATOUS (Arm tight like a sunburn), VACCINATION SITE WARMTH (Arm hot to the touch) and VACCINATION SITE BRUISING (Big red circle) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE DYSAESTHESIA (Left arm felt weird) and VACCINATION SITE MOVEMENT IMPAIRMENT (Arm felt tight). On 18-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Arm tight like a sunburn), VACCINATION SITE WARMTH (Arm hot to the touch), VACCINATION SITE BRUISING (Big red circle), PAIN IN EXTREMITY (Arm pain), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE RASH (Left arm a little splotchy). The patient was treated with MELOXICAM on 18-Mar-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DYSAESTHESIA (Left arm felt weird), VACCINATION SITE MOVEMENT IMPAIRMENT (Arm felt tight), RASH ERYTHEMATOUS (Arm tight like a sunburn), VACCINATION SITE WARMTH (Arm hot to the touch), VACCINATION SITE BRUISING (Big red circle), PAIN IN EXTREMITY (Arm pain), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE RASH (Left arm a little splotchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site reaction, Vaccination site warmth
Clinical narrative: Arm tight like a sunburn; Arm hot to the touch; Big red circle; Arm pain; Covid arm; Left arm a little splotchy; Left arm felt weird; Arm felt tight; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE DYSAESTHESIA (Left arm felt weird), VACCINATION SITE MOVEMENT IMPAIRMENT (Arm felt tight), RASH ERYTHEMATOUS (Arm tight like a sunburn), VACCINATION SITE WARMTH (Arm hot to the touch) and VACCINATION SITE BRUISING (Big red circle) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE DYSAESTHESIA (Left arm felt weird) and VACCINATION SITE MOVEMENT IMPAIRMENT (Arm felt tight). On 18-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Arm tight like a sunburn), VACCINATION SITE WARMTH (Arm hot to the touch), VACCINATION SITE BRUISING (Big red circle), PAIN IN EXTREMITY (Arm pain), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE RASH (Left arm a little splotchy). The patient was treated with MELOXICAM on 18-Mar-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DYSAESTHESIA (Left arm felt weird), VACCINATION SITE MOVEMENT IMPAIRMENT (Arm felt tight), RASH ERYTHEMATOUS (Arm tight like a sunburn), VACCINATION SITE WARMTH (Arm hot to the touch), VACCINATION SITE BRUISING (Big red circle), PAIN IN EXTREMITY (Arm pain), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE RASH (Left arm a little splotchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Gait disturbance, Movement disorder, Tremor
Clinical narrative: Hard time walking; Hands and legs are shaking/ Shaking too bad; Discovered couldn't get up from recliner; Got bad chills; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hard time walking), TREMOR (Hands and legs are shaking/ Shaking too bad), MOVEMENT DISORDER (Discovered couldn't get up from recliner) and CHILLS (Got bad chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 092971A) for COVID-19 vaccination.     Concurrent medical conditions included Dizziness.   On 08-Mar-2021 at 10:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced CHILLS (Got bad chills). On 09-Mar-2021, the patient experienced GAIT DISTURBANCE (Hard time walking), TREMOR (Hands and legs are shaking/ Shaking too bad) and MOVEMENT DISORDER (Discovered couldn't get up from recliner). At the time of the report, GAIT DISTURBANCE (Hard time walking), TREMOR (Hands and legs are shaking/ Shaking too bad), MOVEMENT DISORDER (Discovered couldn't get up from recliner) and CHILLS (Got bad chills) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Limb discomfort, Pain in extremity, Pyrexia, Vaccination site discomfort
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was put almost at the top of my shoulder where i can feel bone and there is very little), PAIN IN EXTREMITY (arm is still hurting), VACCINATION SITE MOVEMENT IMPAIRMENT (I can´t raise my arm like I used to), LIMB DISCOMFORT (it even interfers with dressing myself) and VACCINATION SITE DISCOMFORT (had quite a bit of discomfort when it was injected) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 010A2*A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was put almost at the top of my shoulder where i can feel bone and there is very little), PAIN IN EXTREMITY (arm is still hurting), VACCINATION SITE DISCOMFORT (had quite a bit of discomfort when it was injected), PYREXIA (had some fever (100.2 F)) and PYREXIA (fever went back up like 3 times). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I can´t raise my arm like I used to) and LIMB DISCOMFORT (it even interfers with dressing myself). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was put almost at the top of my shoulder where i can feel bone and there is very little), PAIN IN EXTREMITY (arm is still hurting), VACCINATION SITE MOVEMENT IMPAIRMENT (I can´t raise my arm like I used to), LIMB DISCOMFORT (it even interfers with dressing myself), VACCINATION SITE DISCOMFORT (had quite a bit of discomfort when it was injected), PYREXIA (had some fever (100.2 F)) and PYREXIA (fever went back up like 3 times) outcome was unknown.            Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was put almost at the top of my shoulder where i can feel bone and there is very little), PAIN IN EXTREMITY (arm is still hurting), VACCINATION SITE MOVEMENT IMPAIRMENT (I can´t raise my arm like I used to), LIMB DISCOMFORT (it even interfers with dressing myself) and VACCINATION SITE DISCOMFORT (had quite a bit of discomfort when it was injected) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 010A2*A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was put almost at the top of my shoulder where i can feel bone and there is very little), PAIN IN EXTREMITY (arm is still hurting), VACCINATION SITE DISCOMFORT (had quite a bit of discomfort when it was injected), PYREXIA (had some fever (100.2 F)) and PYREXIA (fever went back up like 3 times). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I can´t raise my arm like I used to) and LIMB DISCOMFORT (it even interfers with dressing myself). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was put almost at the top of my shoulder where i can feel bone and there is very little), PAIN IN EXTREMITY (arm is still hurting), VACCINATION SITE MOVEMENT IMPAIRMENT (I can´t raise my arm like I used to), LIMB DISCOMFORT (it even interfers with dressing myself), VACCINATION SITE DISCOMFORT (had quite a bit of discomfort when it was injected), PYREXIA (had some fever (100.2 F)) and PYREXIA (fever went back up like 3 times) outcome was unknown.            Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Swelling
Clinical narrative: Weird swelling blisters on the left side of he lip; Swelling blisters on left side of lip; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Weird swelling blisters on the left side of he lip) and SWELLING (Swelling blisters on left side of lip) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced BLISTER (Weird swelling blisters on the left side of he lip) and SWELLING (Swelling blisters on left side of lip). At the time of the report, BLISTER (Weird swelling blisters on the left side of he lip) and SWELLING (Swelling blisters on left side of lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included birth control.  No treatment information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site pain, Vaccination site swelling
Clinical narrative: The site of injection is dark purple; The site of injection is sore/ painful; Swelling (size of an orange); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (The site of injection is dark purple), VACCINATION SITE PAIN (The site of injection is sore/ painful) and VACCINATION SITE SWELLING (Swelling (size of an orange)) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (The site of injection is dark purple), VACCINATION SITE PAIN (The site of injection is sore/ painful) and VACCINATION SITE SWELLING (Swelling (size of an orange)). At the time of the report, VACCINATION SITE DISCOLOURATION (The site of injection is dark purple), VACCINATION SITE PAIN (The site of injection is sore/ painful) and VACCINATION SITE SWELLING (Swelling (size of an orange)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.   This case was linked to MOD-2021-114285 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Additional information received included no new information.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Inappropriate schedule of product administration, Injection site erythema, Injection site rash, Pain in extremity
Clinical narrative: upset stomach; red rash at injection site; red rash at injection site; Sore arm; past 36 days from first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (upset stomach), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (past 36 days from first dose), INJECTION SITE RASH (red rash at injection site) and INJECTION SITE ERYTHEMA (red rash at injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 032L20A) for COVID-19 vaccination.     No relevant medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and METOPROLOL for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (past 36 days from first dose). On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), INJECTION SITE RASH (red rash at injection site) and INJECTION SITE ERYTHEMA (red rash at injection site). On 15-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach). On 11-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (past 36 days from first dose) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), INJECTION SITE RASH (red rash at injection site) and INJECTION SITE ERYTHEMA (red rash at injection site) had resolved and ABDOMINAL DISCOMFORT (upset stomach) outcome was unknown.            No treatment medication was reported.  Action taken with mRNA-1273 with respect to events was not applicable.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: red; itching; pain at site; rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at site), VACCINATION SITE RASH (rash on arm), VACCINATION SITE PRURITUS (itching) and ERYTHEMA (red) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at site), VACCINATION SITE RASH (rash on arm), VACCINATION SITE PRURITUS (itching) and ERYTHEMA (red). At the time of the report, VACCINATION SITE PAIN (pain at site), VACCINATION SITE RASH (rash on arm), VACCINATION SITE PRURITUS (itching) and ERYTHEMA (red) outcome was unknown.            No concomitant products reported. Benadryl was used as a treatment product. Action taken with mRNA-1273 in response to the events was Not Applicable.     This case was linked to MOD21-051781 (E2B Linked Report).; Sender's Comments:  MOD21-051781:cross link
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Vaccination site erythema, Vaccination site induration, Vaccination site mass, Vaccination site pain
Clinical narrative: Lump at injection site/ Like a hard ball like trying to get into my blood it's like getting into my veins,like it's going to my blood vessels slowly; Like a hard ball like; Lump hurts when touched; Red spot at injection site; Palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations), VACCINATION SITE MASS (Lump at injection site/ Like a hard ball like trying to get into my blood it's like getting into my veins,like it's going to my blood vessels slowly), VACCINATION SITE INDURATION (Like a hard ball like), VACCINATION SITE PAIN (Lump hurts when touched) and VACCINATION SITE ERYTHEMA (Red spot at injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 14M20A and 004M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient took Tylenol, just have a little fever, but was not hospitalized.) in September 2020. Concomitant products included METOPROLOL, RIVAROXABAN (XARELTO), SIMVASTATIN, OMEPRAZOLE, VITAMIN D NOS, ZINC and PARACETAMOL (TYLENOL) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PALPITATIONS (Palpitations). On an unknown date, the patient experienced VACCINATION SITE MASS (Lump at injection site/ Like a hard ball like trying to get into my blood it's like getting into my veins,like it's going to my blood vessels slowly), VACCINATION SITE INDURATION (Like a hard ball like), VACCINATION SITE PAIN (Lump hurts when touched) and VACCINATION SITE ERYTHEMA (Red spot at injection site). At the time of the report, PALPITATIONS (Palpitations), VACCINATION SITE MASS (Lump at injection site/ Like a hard ball like trying to get into my blood it's like getting into my veins,like it's going to my blood vessels slowly), VACCINATION SITE INDURATION (Like a hard ball like), VACCINATION SITE PAIN (Lump hurts when touched) and VACCINATION SITE ERYTHEMA (Red spot at injection site) had resolved.            No treatment information was provided. Patient stated that she was scheduled for an operation, surgery for her Pacemaker the week after she took the second dose of vaccine as reported.   This case was linked to MOD-2021-051766.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up received on 19-Jul-2021 contains significant information. The event outcome was updated from unknown to recovered/ resolved.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Migraine
Clinical narrative: migraine headache; some flashes; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache) and FLUSHING (some flashes) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Lymphadenectomy.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced FLUSHING (some flashes). On 18-Feb-2021, the patient experienced MIGRAINE (migraine headache). The patient was treated with PARACETAMOL (TYLENOL) for Migraine headache, at an unspecified dose and frequency. On 17-Feb-2021, FLUSHING (some flashes) had resolved. At the time of the report, MIGRAINE (migraine headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products reported. It was reported that she was not going to take the second dose.